Patrick Bilbo - 10 Nov 2021 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
Chief Operating Officer
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Issuer symbol
ORGO
Transactions as of
10 Nov 2021
Net transactions value
+$43,848
Form type
4
Filing time
12 Nov 2021, 17:01:45 UTC
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Options Exercise $43,848 +30,450 +30% $1.44 133,670 10 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORGO Stock Option (Right to Buy) Options Exercise $0 -30,450 -100% $0.000000* 0 10 Nov 2021 Class A Common Stock 30,450 $1.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person transferred 60,900 shares of Class A Common Stock held by the reporting person to his former spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his former spouse.
F2 100% of the shares subject to this option are fully vested and exercisable.